11-Year Study of Fentanyl in Driving Under the Influence of Drugs Casework
- 18 May 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Analytical Toxicology
- Vol. 46 (3) , 337-341
Abstract
Prior to 2017, heroin and other prescription opioids were the most prevalent opioids implicated in driving under the influence of drugs (DUID) investigation cases, and fentanyl was rarely included in the scope of toxicological analysis. Fentanyl has become the most frequently identified opioid in DUID cases, with many suspected heroin cases turning out to be only fentanyl. A review of fentanyl-positive DUID cases at NMS Labs was performed to provide prevalence information, change in concentration, patterns of combined drug use, indicators of impairment and driving behavior in order to assist with the toxicological interpretation of DUID scenarios involving fentanyl. Fentanyl-positive DUID cases received between January 2010 and December 2020 were examined. Blood results were confirmed and quantitated for fentanyl, norfentanyl and acetylfentanyl using a liquid chromatography--tandem mass spectrometry analysis with a limit of quantitation of 0.10, 0.20 and 0.10 ng/mL, respectively. Of 153,234 blood cases examined for DUID over 11 years, fentanyl was confirmed positive in 6,779 (4.4%) cases. However, there were significant changes in positivity over time. Fentanyl percentage positivity increased from 0.60% in 2010 to 12% in 2020. Of 5,976 confirmed fentanyl-positive cases in 2018–2020, blood concentrations >4.0 ng/mL were observed in 44% (2018), 55% (2019) and 59% (2020) of cases. Polypharmacy was common with 87% of blood samples confirmed positive for fentanyl and at least one other compound. Stimulant was the most commonly identified drug class in cases where at least one additional drug class was present. This study illustrates the importance of including fentanyl in a routine blood DUID panel.Keywords
This publication has 8 references indexed in Scilit:
- Increasing presence of xylazine in heroin and/or fentanyl deaths, Philadelphia, Pennsylvania, 2010–2019Injury Prevention, 2021
- Xylazine, a Veterinary Tranquilizer, Detected in 42 Accidental Fentanyl Intoxication DeathsAmerican Journal of Forensic Medicine & Pathology, 2020
- Fentanyl and Driving ImpairmentJournal of Analytical Toxicology, 2020
- Epidemiology of fentanyl-involved drug overdose deaths: A geospatial retrospective study in Rhode Island, USAInternational Journal of Drug Policy, 2017
- Xylazine intoxication in humans and its importance as an emerging adulterant in abused drugs: A comprehensive review of the literatureForensic Science International, 2014
- Transdermal fentanyl: Pharmacology and toxicologyJournal of Medical Toxicology, 2009
- Driving Ability Under Long-Term Treatment with Transdermal FentanylJournal of Pain and Symptom Management, 2003
- Driving Ability After Intravenous Fentanyl or DiazepamInvestigative Radiology, 1986